HEALTHMay 25 · 11:00 UTCFOX NEWS

Experimental Alzheimer’s drug could reduce alcohol withdrawal damage, researchers say

An experimental Alzheimer’s drug called MW150 may reduce brain inflammation during alcohol withdrawal, potentially lowering relapse risks in alcohol use disorder. The study, led by University of Kentucky researchers, suggests MW150 could be repurposed for alcohol-related conditions if further trials confirm its efficacy.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

MW150topicLinda Van EldikpersonCaleb BaileypersonUniversity of Kentucky's Sanders-Brown Center on AgingorganizationAlcohol (journal)organizationAlzheimer’s diseasetopicalcohol use disordertopicNeflamapimodtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHApr 30 · 22:45 UTC
Active ingredient in Ozempic shows early promise for treating alcohol use disorder
HEALTHMay 7 · 21:02 UTC
Cancer warning labels on alcohol may motivate people to drink less, study says
HEALTHMay 7 · 21:02 UTC
Alcohol warning labels that link drinking to cancer are effective, study says
HEALTHMay 4 · 05:42 UTC
Alzheimer’s drugs may not work and could raise brain risks
HEALTHApr 15 · 10:58 UTC
I drank six bottles of wine every weekend, followed by several beers and gin. Now I can stop at just one... and it's all thanks to this tiny, cheap little-known pill
HEALTHMay 17 · 00:56 UTC
I used to drink two bottles of wine a night - then I started taking Mounjaro... and I stopped boozing overnight. So why won't NHS prescribe the jabs to problem drinkers?